Why This Trader Is Watching Amgen

Loading...
Loading...

Christian Tharp was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. Tune in to the daily broadcast live Monday-Friday at 8 a.m. ET here.

 

Amongst several other biotech stocks to which he looked into, Stock Coach Christian Tharp, CMT, mentioned Amgen, Inc. AMGN as a stock he would watch. The company’s stock has gained about 40 percent over the past year, but only 1.7 percent year-to-date.

The trader explains that this is a stock he likes to watch because “it has taken part in the biotech rally in the last couple of weeks,” and he loves seeing something on a chart (“a problem or a good thing,” he says) that tells him what to do, instead of having to guess.

He continues: “Amgen seems to be stalling around this $172 area… it’s done it two or three times… So, this is one that, if someone is looking to get in biotech, is looking to get in Amgen, this stock pushing through that area, I think would make great sense.”

Shares of Amgen are down roughly 2.5 percent on Friday afternoon.

The company will announce its first quarter financial results next Tuesday, April 21. The Estimize consensus for EPS stands at $2.10, versus the Street’s $2.09.

 

Loading...
Loading...
Posted In: BiotechLong IdeasHealth CareOpinionExclusivesTrading IdeasGeneralChristian TharpPreMarketPrep
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...